Publications

You can also find my articles on my Google Scholar profile.

Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial
LR Williams et al.
Vaccine (2024) — Link

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
RE Drury et al.
Nature Communications (2024) — Link

Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach
DJ Phillips, MD Christodoulou, S Feng, AJ Pollard, M Voysey, D Steinsaltz
Preprint (2024) — Link

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
SAC Clemens et al.
Nature Communications (2021) — Link

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
S Feng et al.
Nature Medicine (2021) — Link

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
M Voysey et al.
The Lancet (2021) — Link

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
KJ Ewer et al.
Nature Medicine (2021) — Link

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
JR Barrett et al.
Nature Medicine (2021) — Link

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey et al.
The Lancet (2021) — Link

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy et al.
The Lancet (2020) — Link